SOTYKTU is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Deucravacitinib.
| Product ID | 0003-0895_ff4d7258-5068-4cdf-9692-8cae04c3198e |
| NDC | 0003-0895 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SOTYKTU |
| Generic Name | Deucravacitinib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-09-09 |
| Marketing Category | NDA / |
| Application Number | NDA214958 |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Substance Name | DEUCRAVACITINIB |
| Active Ingredient Strength | 6 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-09-09 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SOTYKTU 97558218 not registered Live/Pending |
Bristol-Myers Squibb Company 2022-08-22 |
![]() SOTYKTU 97287564 not registered Live/Pending |
Bristol-Myers Squibb Company 2022-02-28 |
![]() SOTYKTU 90718747 not registered Live/Pending |
Bristol-Myers Squibb Company 2021-05-18 |